These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 38714621)
1. Analysis of cognitive dysfunction in Parkinson's disease using voxel based morphometry and radiomics. Sivaranjini S; Sujatha CM Cogn Process; 2024 Aug; 25(3):521-532. PubMed ID: 38714621 [TBL] [Abstract][Full Text] [Related]
2. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition. Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799 [TBL] [Abstract][Full Text] [Related]
3. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology. Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894 [TBL] [Abstract][Full Text] [Related]
4. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease. Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642 [TBL] [Abstract][Full Text] [Related]
5. Regional gray matter reductions associated with mild cognitive impairment in Parkinson's disease: A meta-analysis of voxel-based morphometry studies. Zheng D; Chen C; Song W; Yi Z; Zhao P; Zhong J; Dai Z; Shi H; Pan P Behav Brain Res; 2019 Oct; 371():111973. PubMed ID: 31128163 [TBL] [Abstract][Full Text] [Related]
6. Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease. Xu Y; Yang J; Hu X; Shang H J Neurol; 2016 Jun; 263(6):1178-87. PubMed ID: 27113603 [TBL] [Abstract][Full Text] [Related]
7. Functional and structural changes in gray matter of parkinson's disease patients with mild cognitive impairment. Chen B; Wang S; Sun W; Shang X; Liu H; Liu G; Gao J; Fan G Eur J Radiol; 2017 Aug; 93():16-23. PubMed ID: 28668411 [TBL] [Abstract][Full Text] [Related]
8. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment. Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006 [TBL] [Abstract][Full Text] [Related]
9. Neuroanatomical changes in early Parkinson's disease with mild cognitive impairment: a VBM study; the Parkinson's Disease Cognitive Impairment Study (PaCoS). Donzuso G; Monastero R; Cicero CE; Luca A; Mostile G; Giuliano L; Baschi R; Caccamo M; Gagliardo C; Palmucci S; Zappia M; Nicoletti A Neurol Sci; 2021 Sep; 42(9):3723-3731. PubMed ID: 33447925 [TBL] [Abstract][Full Text] [Related]
13. Reduced gray matter volume is correlated with frontal cognitive and behavioral impairments in Parkinson's disease. Terada T; Miyata J; Obi T; Kubota M; Yoshizumi M; Murai T J Neurol Sci; 2018 Jul; 390():231-238. PubMed ID: 29801896 [TBL] [Abstract][Full Text] [Related]
14. Voxel-wise meta-analysis of structural changes in gray matter of Parkinson's disease patients with mild cognitive impairment. Qin B; Yang MX; Gao W; Zhang JD; Zhao LB; Qin HX; Chen H Braz J Med Biol Res; 2020; 53(6):e9275. PubMed ID: 32428131 [TBL] [Abstract][Full Text] [Related]
15. Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage. Agosta F; Canu E; Stefanova E; Sarro L; Tomić A; Špica V; Comi G; Kostić VS; Filippi M Hum Brain Mapp; 2014 May; 35(5):1921-9. PubMed ID: 23843285 [TBL] [Abstract][Full Text] [Related]
16. Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease-Related Cognitive Impairment. Oh Y; Kim JS; Lyoo CH; Park G; Kim H Neurology; 2024 Jul; 103(2):e209498. PubMed ID: 38885485 [TBL] [Abstract][Full Text] [Related]
17. Neurodegeneration across stages of cognitive decline in Parkinson disease. Weintraub D; Doshi J; Koka D; Davatzikos C; Siderowf AD; Duda JE; Wolk DA; Moberg PJ; Xie SX; Clark CM Arch Neurol; 2011 Dec; 68(12):1562-8. PubMed ID: 22159053 [TBL] [Abstract][Full Text] [Related]
18. Structural neuroimaging changes associated with subjective cognitive decline from a clinical sample. Riverol M; Ríos-Rivera MM; Imaz-Aguayo L; Solis-Barquero SM; Arrondo C; Montoya-Murillo G; Villino-Rodríguez R; García-Eulate R; Domínguez P; Fernández-Seara MA Neuroimage Clin; 2024; 42():103615. PubMed ID: 38749146 [TBL] [Abstract][Full Text] [Related]
19. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? Duncan GW; Firbank MJ; Yarnall AJ; Khoo TK; Brooks DJ; Barker RA; Burn DJ; O'Brien JT Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802 [TBL] [Abstract][Full Text] [Related]
20. Reduced lateral occipital gray matter volume is associated with physical frailty and cognitive impairment in Parkinson's disease. Chen YS; Chen HL; Lu CH; Chen MH; Chou KH; Tsai NW; Yu CC; Chiang PL; Lin WC Eur Radiol; 2019 May; 29(5):2659-2668. PubMed ID: 30523452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]